Short answer · Medically reviewed summary · Last updated: 2023-07-13
Binder's syndrome, also known as maxillonasal dysplasia, is a rare congenital craniofacial disorder characterized by underdevelopment of the midface and nasal structures. It is named after Dr.
What is the prevalence of Binder's syndrome?
Prevalence of Binder's syndrome: how many people are affected worldwide, differences by sex and region, with sources.
Binder's syndrome, also known as maxillonasal dysplasia, is a rare congenital craniofacial disorder characterized by underdevelopment of the midface and nasal structures. It is named after Dr. David Binder, who first described the condition in 1962.
The prevalence of Binder's syndrome is not well-documented in the medical literature, making it difficult to provide an exact figure. However, it is generally considered to be a relatively uncommon condition. The rarity of Binder's syndrome can be attributed to its complex etiology, which is not yet fully understood.
Individuals with Binder's syndrome typically exhibit a flattened or retruded midface, a short or absent nasal bridge, and a cleft or pseudocleft of the hard palate. These facial abnormalities can vary in severity among affected individuals.
Diagnosis of Binder's syndrome is usually made based on clinical evaluation, medical history, and radiographic imaging. Treatment options for Binder's syndrome may include orthodontic interventions, maxillofacial surgery, and speech therapy, depending on the specific needs of the patient.
While Binder's syndrome is a rare condition, it can have significant physical and psychological impacts on affected individuals. Early diagnosis and appropriate management can help improve the quality of life for those living with this craniofacial disorder.
